Kikuchi H, Tsuiki S
Biochim Biophys Acta. 1976 Jan 23;422(1):241-6. doi: 10.1016/0005-2744(76)90023-1.
Although human liver contains glucosaminephosphate synthase (glucosaminephosphate isomerase (glutamine-forming), EC 5.3.1.19), its activity is rapidly lost during the course of extraction. The inactivation, however, is largely prevented if the extraction medium contains isopropanol at 1% concentration; using these "stabilized" extracts, the glucosaminephosphate synthase activity of human liver has been shown to be similar to the activity previously reported in rat liver. The enzyme precipitated from these extracts by (NH4)2SO4 is inhibited by UDP-N-acetylglucosamine, the concentration required to produce a half-maximal inhibition being 6 muM. These results seem to be sufficient to postulate that glucosaminephosphate synthase is important for UDP-N-acetylglucosamine synthesis in human liver. In contrast to the rat liver enzyme, the (NH4)2SO4-precipitated human liver enzyme is resistant to trypsin and undergoes no conversion reaction when incubated with glucose 6-phosphate.
尽管人类肝脏含有氨基葡萄糖磷酸合酶(氨基葡萄糖磷酸异构酶(谷氨酰胺形成型),EC 5.3.1.19),但其活性在提取过程中会迅速丧失。然而,如果提取介质中含有1%浓度的异丙醇,则可在很大程度上防止这种失活;使用这些“稳定化”提取物,已证明人类肝脏的氨基葡萄糖磷酸合酶活性与先前报道的大鼠肝脏中的活性相似。从这些提取物中通过硫酸铵沉淀得到的酶受到UDP-N-乙酰葡糖胺的抑制,产生半数最大抑制所需的浓度为6μM。这些结果似乎足以推测氨基葡萄糖磷酸合酶对人类肝脏中UDP-N-乙酰葡糖胺的合成很重要。与大鼠肝脏酶不同,经硫酸铵沉淀的人类肝脏酶对胰蛋白酶具有抗性,并且与6-磷酸葡萄糖一起孵育时不发生转化反应。